Proteolysis‐triggered RNA Interference for Mitochondrial Iron Dyshomeostasis to Activate Antitumor Immunity in Hepatic Carcinoma
Authors:
- 4 August 2025
- journal article
- Published by Wiley in Advanced Materials
- Vol. 37 (42) , e08457
Abstract
Although the disturbance of iron metabolism holds significant promise for antitumor therapy, the specific regulation of the precise acting site remains challenging. Here, a self‐triggering proteolysis RNA interference system (cRGD‐VFs) is elaborately constructed to precisely disturb mitochondrial iron homeostasis, the core hub of cellular iron regulation, for evoking antitumor immunity. Specifically, ferritin is conjugated with E3 ligase ligand VH032 and tumor‐targeting cRGD peptide through click chemistry, and further loaded with ENO1‐targeted siRNA to prepare cRGD‐VFs. Following the targeted uptake by tumor cells, cRGD‐VFs recruits E3 ligase to initiate the ubiquitination process to trigger the proteolysis of ferritin, resulting in the release of abundant Fe 2+ and the loaded siRNA. siRNA‐mediated ENO1‐targeted knockdown would upregulate the mitochondrial iron transport channel through the ENO1‐IRP1‐Mfrn1 pathway, which subsequently leads to mitochondrial iron overload and the increase of detrimental mitochondrial reactive oxygen species (ROS), thereby triggering severe mitochondria destruction and causing mass death of tumor cells. Noteworthily, it is found that cRGD‐VFs‐mediated mitochondrial iron overload can activate powerful antitumor immunity by upregulating immune‐related pathways to eliminate tumors, achieving notable tumor suppression in multiple murine liver cancer models, which represents a promising strategy of disturbing mitochondrial iron homeostasis for potentiating antitumor immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (52473145, 52333004, 52273301, 52131302, 22135005)
This publication has 40 references indexed in Scilit:
- Glucose Metabolism‐Targeted Poly(amino acid) Nanoformulation of Oxaliplatin(IV)‐Aspirin Prodrug for Enhanced Chemo‐ImmunotherapyAdvanced Materials, 2025
- Disrupting Intracellular Homeostasis by Copper‐Based Nanoinducer with Multiple Enzyme‐Mimicking Activities to Induce Disulfidptosis‐Enhanced Pyroptosis for Tumor ImmunotherapyAdvanced Materials, 2024
- Tumor Microenvironment‐Activatable Metal‐Phenolic Nanoformulations for Ultrasound‐Boosted Ferroptosis through Triple Regulatory PathwaysAdvanced Functional Materials, 2024
- A PD‐L1‐targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition‐Mediated Synergistic Antitumor Metabolic and Immune TherapyAdvanced Materials, 2023
- A Semiconducting Iron‐Chelating Nano‐immunomodulator for Specific and Sensitized Sono‐metallo‐immunotherapy of CancerAngewandte Chemie International Edition, 2023
- Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer ImmunotherapyAngewandte Chemie International Edition, 2023
- Smart Nano‐PROTACs Reprogram Tumor Microenvironment for Activatable Photo‐metabolic Cancer ImmunotherapyAngewandte Chemie International Edition, 2021
- Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic‐Synergized Multimodal TherapyAdvanced Materials, 2021
- Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrierAdvanced Drug Delivery Reviews, 2021
- A Multichannel Ca2+ Nanomodulator for Multilevel Mitochondrial Destruction‐Mediated Cancer TherapyAdvanced Materials, 2021